The report by Liu et al. (13) underscores the pivotal role of Toe-Macs in the pathogenesis of MASH, NSCLC, and endometriosis, thereby offering a rationale for investigating TET3 as a potential therapeutic target. The gene discussed is TET3; the disease is metabolic dysfunction-associated steatohepatitis.